ArticleP & T : a peer-reviewed journal for formulary management2009
Rosacea: a review.
Article in P & T : a peer-reviewed journal for formulary management, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- Interventions for rosacea.The Cochrane database of systematic reviews · 2015Pooled it
- Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review.Journal of cutaneous medicine and surgeryPooled it
- Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea.Journal of cosmetic dermatology · 2012Trial
- Effective Treatment of Rosacea and Telangiectasias Using IPL.Journal of cosmetic dermatology · 2025Article
- A Cross-Sectional Survey of the Relationship between Rosacea andJournal of arthropod-borne diseases · 2025Article
- Ocular Rosacea: An Updated Review.Cornea · 2025Review
- Emulgel Containing Metronidazole and Clindamycin for the Treatment of Rosacea.Pharmaceutics · 2025Article
- Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses.Clinical ophthalmology (Auckland, N.Z.) · 2024Review
- Long-term Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From an Extension of Two Phase III, Vehicle-controlled Trials.The Journal of clinical and aesthetic dermatology · 2023Article
- Efficacy and Safety of the Genistein Nutraceutical Product Containing Vitamin E, Vitamin B3, and Ceramide on Skin Health in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Journal of clinical medicine · 2023Article
- mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea.Frontiers in cell and developmental biology · 2021Article
- Article
- Starch-Based Pickering Emulsions as Platforms for Topical Antibiotic Delivery: In Vitro and In Vivo Studies.Polymers · 2019Article
- The Prevalence of Sensitive Skin.Frontiers in medicine · 2019Review
- Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study.American health & drug benefits · 2018Article
- Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.American health & drug benefits · 2017Article
- Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.Current opinion in ophthalmology · 2017Review
- Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.Advances in therapy · 2016Review
- The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis.SpringerPlus · 2016Article
- Rosacea Patient Perspectives on Homeopathic and Over-the-counter Therapies.The Journal of clinical and aesthetic dermatology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosacea is a chronic inflammatory condition of the facial skin affecting the blood vessels and pilosebaceous units. Rosacea is more common in persons of northern and western European descent with a fair complexion, but it can affect skin of any color. Although symptoms may wax and wane during the short term, rosacea can progress with time. Patients usually present with complaints of flushing and blushing and sensitive skin, and their skin may be especially irritated by topical preparations. Rosacea has a variety of triggers; however, they may be unnoticed by the patient.Standard treatments approved by the FDA include azelaic acid, topical metronidazole, and oral tetracyclines, in particular minocycline and doxycycline. Other topical treatments include topical clindamycin, subantimicrobial-dose doxycycline, and sulfur products. Azithromycin and controlled-release minocycline are possible options for treating rosacea, but the FDA has not approved either agent for this indication.
Identifiers
19562004PMC2700634W1535641496What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.